Completed PHASE2 INTERVENTIONAL 2-arm NCT02513329

Stellate Ganglion Block (SGB) For Women for Breast Cancer

Effects of Stellate Ganglion Block (SGB) on Vasomotor Symptoms in Women Receiving Anti-Estrogen Therapy for Breast Cancer

Sponsor: Northwestern University

Conditions Hot Flashes Hot Flushes

Interventions Bupivicaine Saline

Updated 10 times since 2017 Last updated: Jun 1, 2023 Started: Jul 31, 2015 Primary completion: Jan 31, 2020 Completion: Jan 31, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Hot Flashes and Hot Flushes, this trial is completed. The trial is conducted by Northwestern University and has accumulated 10 data snapshots since 2015. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

10 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jul 2023 — Jul 2024 [monthly]

Completed PHASE2
Jan 2022 — Jul 2023 [monthly]

Completed PHASE2

Status: Active Not Recruiting → Completed
Jan 2021 — Jan 2022 [monthly]

Active Not Recruiting PHASE2

▶ Show 5 earlier versions

Aug 2020 — Jan 2021 [monthly]

Active Not Recruiting PHASE2

Status: Recruiting → Active Not Recruiting
Sep 2019 — Aug 2020 [monthly]

Recruiting PHASE2
Oct 2018 — Sep 2019 [monthly]

Recruiting PHASE2
Jun 2018 — Oct 2018 [monthly]

Recruiting PHASE2
Jan 2017 — Jun 2018 [monthly]

Recruiting PHASE2

First recorded

Jul 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Northwestern University
University of Illinois at Chicago

Data source: Northwestern University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Chicago, United States